Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 3700 (117th)

Affordable Insulin Now Act

referredUnited States· United States Congress· EN

Introduced

17 February 2022

Last action

17 February 2022 · Introduced

Status

Read twice and referred to the Committee on Finance.

Sponsors

Sen. Warnock, Raphael G. [D-GA], Sen. Schumer, Charles E. [D-NY], Sen. Durbin, Richard J. [D-IL], Sen. Wyden, Ron [D-OR], Sen. Bennet, Michael F. [D-CO], Sen. Blumenthal, Richard [D-CT], Sen. Baldwin, Tammy [D-WI], Sen. Kelly, Mark [D-AZ], Sen. Stabenow, Debbie [D-MI], Sen. Reed, Jack [D-RI], Sen. Van Hollen, Chris [D-MD], Sen. Hirono, Mazie K. [D-HI], Sen. Klobuchar, Amy [D-MN], Sen. Murphy, Christopher [D-CT], Sen. Hassan, Margaret Wood [D-NH], Sen. Shaheen, Jeanne [D-NH], Sen. Booker, Cory A. [D-NJ], Sen. King, Angus S., Jr. [I-ME], Sen. Smith, Tina [D-MN], Sen. Padilla, Alex [D-CA], Sen. Peters, Gary C. [D-MI], Sen. Whitehouse, Sheldon [D-RI], Sen. Rosen, Jacky [D-NV], Sen. Brown, Sherrod [D-OH], Sen. Cortez Masto, Catherine [D-NV], Sen. Manchin, Joe, III [D-WV], Sen. Merkley, Jeff [D-OR], Sen. Hickenlooper, John W. [D-CO], Sen. Menendez, Robert [D-NJ], Sen. Casey, Robert P., Jr. [D-PA], Sen. Sinema, Kyrsten [I-AZ], Sen. Duckworth, Tammy [D-IL], Sen. Heinrich, Martin [D-NM], Sen. Feinstein, Dianne [D-CA], Sen. Kaine, Tim [D-VA], Sen. Luján, Ben Ray [D-NM], Sen. Carper, Thomas R. [D-DE]

Subjects

Healthcare

Source updated

3 January 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Affordable Insulin Now Act This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023. The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare & Medicaid Services (CMS) to implement the bill. Currently, the CMS is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 17 February 2022

    Introduced

    Read twice and referred to the Committee on Finance.

    Source: IntroReferral

  2. 17 February 2022

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 17 February 2022

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 17 February 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 17 February 2022

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.